Skip to main content
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses

New Research In

Physical Sciences

Featured Portals

  • Physics
  • Chemistry
  • Sustainability Science

Articles by Topic

  • Applied Mathematics
  • Applied Physical Sciences
  • Astronomy
  • Computer Sciences
  • Earth, Atmospheric, and Planetary Sciences
  • Engineering
  • Environmental Sciences
  • Mathematics
  • Statistics

Social Sciences

Featured Portals

  • Anthropology
  • Sustainability Science

Articles by Topic

  • Economic Sciences
  • Environmental Sciences
  • Political Sciences
  • Psychological and Cognitive Sciences
  • Social Sciences

Biological Sciences

Featured Portals

  • Sustainability Science

Articles by Topic

  • Agricultural Sciences
  • Anthropology
  • Applied Biological Sciences
  • Biochemistry
  • Biophysics and Computational Biology
  • Cell Biology
  • Developmental Biology
  • Ecology
  • Environmental Sciences
  • Evolution
  • Genetics
  • Immunology and Inflammation
  • Medical Sciences
  • Microbiology
  • Neuroscience
  • Pharmacology
  • Physiology
  • Plant Biology
  • Population Biology
  • Psychological and Cognitive Sciences
  • Sustainability Science
  • Systems Biology
Research Article

Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway

Yuki Hirose, View ORCID ProfileTomohiro Kitazono, Maiko Sezaki, Manabu Abe, Kenji Sakimura, Hiromasa Funato, Hiroshi Handa, View ORCID ProfileKaspar E. Vogt, and View ORCID ProfileMasashi Yanagisawa
PNAS September 15, 2020 117 (37) 23106-23112; first published August 26, 2020; https://doi.org/10.1073/pnas.1917701117
Yuki Hirose
aInternational Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomohiro Kitazono
aInternational Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tomohiro Kitazono
Maiko Sezaki
aInternational Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manabu Abe
bDepartment of Cellular Neurobiology, Brain Research Institute, Niigata University, Chuo-ku Niigata 951-8585 Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenji Sakimura
bDepartment of Cellular Neurobiology, Brain Research Institute, Niigata University, Chuo-ku Niigata 951-8585 Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiromasa Funato
aInternational Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan;
cDepartment of Anatomy, Faculty of Medicine, Toho University, Ota-ku, Tokyo 143-8540, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Handa
dDepartment of Chemical Biology, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaspar E. Vogt
aInternational Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kaspar E. Vogt
Masashi Yanagisawa
aInternational Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan;
eDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390;
fLife Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba, 305-8575 Tsukuba, Japan;
gR&D Center for Frontiers of MIRAI in Policy and Technology, University of Tsukuba, 305-8575 Tsukuba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Masashi Yanagisawa
  • For correspondence: yanagisawa.masa.fu@u.tsukuba.ac.jp
  1. Contributed by Masashi Yanagisawa, July 19, 2020 (sent for review October 10, 2019; reviewed by Ying-Hui Fu and Toru Takumi)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Significance

Thalidomide was introduced in 1950s as a safe and effective hypnotic but was subsequently withdrawn from the market due to its devastating teratogenicity in humans. More recently, thalidomide has reemerged as an antineoplastic and immunomodulatory medicine. The teratogenic and immunomodulatory effects of thalidomide have been attributed to direct inhibition of the cereblon-mediated ubiquitin/proteasome pathway. Here we show that cereblon is not involved in the hypnotic effect of thalidomide, using mice that carry a thalidomide-resistant mutant allele of the cereblon gene. Our results suggest the possibility for dissociating the hypnotic effect of thalidomide and its analogs from its teratogenicity.

Abstract

Thalidomide exerts its teratogenic and immunomodulatory effects by binding to cereblon (CRBN) and thereby inhibiting/modifying the CRBN-mediated ubiquitination pathway consisting of the Cullin4-DDB1-ROC1 E3 ligase complex. The mechanism of thalidomide’s classical hypnotic effect remains largely unexplored, however. Here we examined whether CRBN is involved in the hypnotic effect of thalidomide by generating mice harboring a thalidomide-resistant mutant allele of Crbn (Crbn YW/AA knock-in mice). Thalidomide increased non-REM sleep time in Crbn YW/AA knock-in homozygotes and heterozygotes to a similar degree as seen in wild-type littermates. Thalidomide similarly depressed excitatory synaptic transmission in the cortical slices obtained from wild-type and Crbn YW/AA homozygous knock-in mice without affecting GABAergic inhibition. Thalidomide induced Fos expression in vasopressin-containing neurons of the supraoptic nucleus and reduced Fos expression in the tuberomammillary nuclei. Thus, thalidomide’s hypnotic effect seems to share some downstream mechanisms with general anesthetics and GABAA-activating sedatives but does not involve the teratogenic CRBN-mediated ubiquitin/proteasome pathway.

  • cereblon
  • sleep
  • electroencephalography/electromyography (EEG/EMG)
  • supraoptic nucleus
  • mouse

Footnotes

  • ↵1To whom correspondence may be addressed. Email: yanagisawa.masa.fu{at}u.tsukuba.ac.jp.
  • Author contributions: Y.H., H.F., K.E.V., and M.Y. designed research; Y.H., T.K., and M.S. performed research; M.A., K.S., and H.H. contributed new reagents/analytic tools; Y.H. and T.K. analyzed data; and Y.H., K.E.V., and M.Y. wrote the paper.

  • Reviewers: Y.-H.F., University of California, San Francisco; and T.T., RIKEN.

  • The authors declare no competing interest.

Data Availability.

All study data are included in the main text.

Published under the PNAS license.

View Full Text

References

  1. ↵
    1. J. K. Walsh et al.
    , Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). Sleep 34, 997–1011 (2011).
    OpenUrl
  2. ↵
    1. S. Stranges,
    2. W. Tigbe,
    3. F. X. Gómez-Olivé,
    4. M. Thorogood,
    5. N. B. Kandala
    , Sleep problems: An emerging global epidemic? Findings from the INDEPTH WHO-SAGE study among more than 40,000 older adults from 8 countries across Africa and Asia. Sleep 35, 1173–1181 (2012).
    OpenUrlPubMed
  3. ↵
    1. T. L. Schwartz,
    2. V. Goradia
    , Managing insomnia: An overview of insomnia and pharmacologic treatment strategies in use and on the horizon. Drugs Context 2013, 212257 (2013).
    OpenUrl
  4. ↵
    1. G. F. Somers
    , Pharmacological properties of thalidomide (alpha-phthalimido glutarimide), a new sedative hypnotic drug. Br. J. Pharmacol. Chemother. 15, 111–116 (1960).
    OpenUrlPubMed
  5. ↵
    1. H. B. Taussig
    , A study of the German outbreak of phocomelia. The thalidomide syndrome. JAMA 180, 1106–1114 (1962).
    OpenUrlCrossRefPubMed
  6. ↵
    1. I. M. Leck,
    2. E. L. Millar
    , Incidence of malformations since the introduction of thalidomide. BMJ 2, 16–20 (1962).
    OpenUrlFREE Full Text
  7. ↵
    1. W. Lenz,
    2. K. Knapp
    , Thalidomide embryopathy. Arch. Environ. Health 5, 100–105 (1962).
    OpenUrlPubMed
  8. ↵
    1. A. E. Rodin,
    2. L. A. Koller,
    3. J. D. Taylor
    , Association of thalidomide (Kevadon) with congenital anomalies. Can. Med. Assoc. J. 86, 744–746 (1962).
    OpenUrlPubMed
  9. ↵
    1. A. L. Speirs
    , Thalidomide and congenital abnormalities. Lancet 1, 303–305 (1962).
    OpenUrlCrossRefPubMed
  10. ↵
    1. G. S. Somers
    , Thalidomide and congenital abnormalities. Lancet 1, 912–913 (1962).
    OpenUrlPubMed
  11. ↵
    1. I. D. Fratta,
    2. E. B. Sigg,
    3. K. Maiorana
    , Teratogenic effects of thalidomide in rabbits, rats, hamsters, and mice. Toxicol. Appl. Pharmacol. 7, 268–286 (1965).
    OpenUrlCrossRefPubMed
  12. ↵
    1. J. G. Wilson,
    2. R. Fradkin
    , Teratogeny in nonhuman primates, with notes on breeding procedures in Macaca mulatta. Ann. N. Y. Acad. Sci. 162, 267–277 (1969).
    OpenUrlCrossRefPubMed
  13. ↵
    1. L. Levy,
    2. P. Fasal,
    3. N. E. Levan,
    4. R. I. Freedman
    , Treatment of erythema nodosum leprosum with thalidomide. Lancet 2, 324–325 (1973).
    OpenUrlPubMed
  14. ↵
    1. S. Makonkawkeyoon,
    2. R. N. Limson-Pobre,
    3. A. L. Moreira,
    4. V. Schauf,
    5. G. Kaplan
    , Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 90, 5974–5978 (1993).
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. W. A. Hanekom et al.
    , The immunomodulatory effects of thalidomide on human immunodeficiency virus-infected children. J. Infect. Dis. 184, 1192–1196 (2001).
    OpenUrlCrossRefPubMed
  16. ↵
    1. R. J. D’Amato,
    2. M. S. Loughnan,
    3. E. Flynn,
    4. J. Folkman
    , Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 91, 4082–4085 (1994).
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. A. L. Moreira et al.
    , Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med. 177, 1675–1680 (1993).
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. L. G. Corral,
    2. G. Kaplan
    , Immunomodulation by thalidomide and thalidomide analogues. Ann. Rheum. Dis. 58 (suppl. 1), I107–I113 (1999).
    OpenUrlCrossRefPubMed
  19. ↵
    1. M. Larkin
    , Low-dose thalidomide seems to be effective in multiple myeloma. Lancet 354, 925 (1999).
    OpenUrlPubMed
  20. ↵
    1. S. Singhal et al.
    , Antitumor activity of thalidomide in refractory multiple myeloma. N. Engl. J. Med. 341, 1565–1571 (1999).
    OpenUrlCrossRefPubMed
  21. ↵
    1. J. B. Bartlett,
    2. K. Dredge,
    3. A. G. Dalgleish
    , The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nat. Rev. Cancer 4, 314–322 (2004).
    OpenUrlCrossRefPubMed
  22. ↵
    1. T. Ito et al.
    , Identification of a primary target of thalidomide teratogenicity. Science 327, 1345–1350 (2010).
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. J. Krönke et al.
    , Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343, 301–305 (2014).
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. G. Lu et al.
    , The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science 343, 305–309 (2014).
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. J. Krönke et al.
    , Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS. Nature 523, 183–188 (2015).
    OpenUrlCrossRefPubMed
  26. ↵
    1. J. J. Higgins,
    2. J. Pucilowska,
    3. R. Q. Lombardi,
    4. J. P. Rooney
    , A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation. Neurology 63, 1927–1931 (2004).
    OpenUrlCrossRefPubMed
  27. ↵
    1. A. A. Akuffo et al.
    , Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon. J. Biol. Chem. 293, 6187–6200 (2018).
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. J. Lu et al.
    , Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4. Chem. Biol. 22, 755–763 (2015).
    OpenUrlCrossRefPubMed
  29. ↵
    1. N. Sawamura et al.
    , The neuroprotective effect of thalidomide against ischemia through the cereblon-mediated repression of AMPK activity. Sci. Rep. 8, 2459 (2018).
    OpenUrl
  30. ↵
    1. T. Y. Choi et al.
    , BK channel blocker paxilline attenuates thalidomide-caused synaptic and cognitive dysfunctions in mice. Sci. Rep. 8, 17653 (2018).
    OpenUrl
  31. ↵
    1. T. Kanbayashi et al.
    , Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsy. Neuroreport 7, 1881–1886 (1996).
    OpenUrlPubMed
  32. ↵
    1. N. Stavropoulos,
    2. M. W. Young
    , Insomniac and Cullin-3 regulate sleep and wakefulness in Drosophila. Neuron 72, 964–976 (2011).
    OpenUrlCrossRefPubMed
  33. ↵
    1. C. Pfeiffenberger,
    2. R. Allada
    , Cul3 and the BTB adaptor insomniac are key regulators of sleep homeostasis and a dopamine arousal pathway in Drosophila. PLoS Genet. 8, e1003003 (2012).
    OpenUrlCrossRefPubMed
  34. ↵
    1. L.-F. Jiang-Xie et al.
    , A common neuroendocrine substrate for diverse general anesthetics and sleep. Neuron 102, 1053–1065.e4 (2019).
    OpenUrlCrossRefPubMed
  35. ↵
    1. J. Lu et al.
    , Role of endogenous sleep-wake and analgesic systems in anesthesia. J. Comp. Neurol. 508, 648–662 (2008).
    OpenUrlCrossRefPubMed
  36. ↵
    1. T. Kanbayashi et al.
    , Thalidomide increases both REM and stage 3-4 sleep in human adults: A preliminary study. Sleep 22, 113–115 (1999).
    OpenUrlPubMed
  37. ↵
    1. M. M. Eiland et al.
    , Increases in amino-cupric-silver staining of the supraoptic nucleus after sleep deprivation. Brain Res. 945, 1–8 (2002).
    OpenUrlCrossRefPubMed
  38. ↵
    1. Q. Xin,
    2. B. Bai,
    3. W. Liu
    , The analgesic effects of oxytocin in the peripheral and central nervous system. Neurochem. Int. 103, 57–64 (2017).
    OpenUrl
  39. ↵
    1. Y. Meguro et al.
    , Neuropeptide oxytocin enhances μ opioid receptor signaling as a positive allosteric modulator. J. Pharmacol. Sci. 137, 67–75 (2018).
    OpenUrl
  40. ↵
    1. T. B. Sloan
    , Anesthetic effects on electrophysiologic recordings. J. Clin. Neurophysiol. 15, 217–226 (1998).
    OpenUrlCrossRefPubMed
  41. ↵
    1. Y. Liu et al.
    , A novel effect of thalidomide and its analogs: Suppression of cereblon ubiquitination enhances ubiquitin ligase function. FASEB J. 29, 4829–4839 (2015).
    OpenUrlCrossRefPubMed
  42. ↵
    1. J. Kono et al.
    , Distribution of corticotropin-releasing factor neurons in the mouse brain: A study using corticotropin-releasing factor-modified yellow fluorescent protein knock-in mouse. Brain Struct. Funct. 222, 1705–1732 (2017).
    OpenUrlCrossRefPubMed
  43. ↵
    1. R. M. Chemelli et al.
    , Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell 98, 437–451 (1999).
    OpenUrlCrossRefPubMed
  44. ↵
    1. S. E. Reed,
    2. E. M. Staley,
    3. J. P. Mayginnes,
    4. D. J. Pintel,
    5. G. E. Tullis
    , Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors. J. Virol. Methods 138, 85–98 (2006).
    OpenUrlCrossRefPubMed

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

Subscribers, for more details, please visit our Subscriptions FAQ.

Please click here to log into the PNAS submission website.

PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway
Yuki Hirose, Tomohiro Kitazono, Maiko Sezaki, Manabu Abe, Kenji Sakimura, Hiromasa Funato, Hiroshi Handa, Kaspar E. Vogt, Masashi Yanagisawa
Proceedings of the National Academy of Sciences Sep 2020, 117 (37) 23106-23112; DOI: 10.1073/pnas.1917701117

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway
Yuki Hirose, Tomohiro Kitazono, Maiko Sezaki, Manabu Abe, Kenji Sakimura, Hiromasa Funato, Hiroshi Handa, Kaspar E. Vogt, Masashi Yanagisawa
Proceedings of the National Academy of Sciences Sep 2020, 117 (37) 23106-23112; DOI: 10.1073/pnas.1917701117
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley
Proceedings of the National Academy of Sciences: 117 (37)
Table of Contents

Submit

Sign up for Article Alerts

Article Classifications

  • Biological Sciences
  • Pharmacology

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Materials and Methods
    • Data Availability.
    • Acknowledgments
    • Footnotes
    • References
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Abstract depiction of a guitar and musical note
Science & Culture: At the nexus of music and medicine, some see disease treatments
Although the evidence is still limited, a growing body of research suggests music may have beneficial effects for diseases such as Parkinson’s.
Image credit: Shutterstock/agsandrew.
Large piece of gold
News Feature: Tracing gold's cosmic origins
Astronomers thought they’d finally figured out where gold and other heavy elements in the universe came from. In light of recent results, they’re not so sure.
Image credit: Science Source/Tom McHugh.
Dancers in red dresses
Journal Club: Friends appear to share patterns of brain activity
Researchers are still trying to understand what causes this strong correlation between neural and social networks.
Image credit: Shutterstock/Yeongsik Im.
White and blue bird
Hazards of ozone pollution to birds
Amanda Rodewald, Ivan Rudik, and Catherine Kling talk about the hazards of ozone pollution to birds.
Listen
Past PodcastsSubscribe
Goats standing in a pin
Transplantation of sperm-producing stem cells
CRISPR-Cas9 gene editing can improve the effectiveness of spermatogonial stem cell transplantation in mice and livestock, a study finds.
Image credit: Jon M. Oatley.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Librarians
  • Press
  • Site Map
  • PNAS Updates

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490